Search results
Earnings call: Palatin Technologies reports Q3 results, plans new trials
Investing.com· 21 hours agoPalatin Technologies, Inc. (NYSE: PTN ) has disclosed its financial results for the third quarter of...
Utah mom sues AstraZeneca, claiming she was left ‘permanently disabled’ in COVID vaccine trial
New York Post· 2 days ago“I walked into the... claims she had signed a consent form with the manufacturer at the beginning of...
New Wegovy clinical trial finds surprising benefits that go way beyond weight loss
KABC 7 Los Angeles· 4 hours agoFor the last few years, we've been hearing how semaglutide weight loss drugs can help with heart failure and heart attack. This week at the European Congress of Obesity, researchers released ...
Vaccine trial patient files first US lawsuit against AstraZeneca
The Telegraph via Yahoo News· 2 days agoAn American woman who took part in the US clinical trial of the AstraZeneca Covid vaccine is suing...
Earnings call: NRx Pharmaceuticals outlines strategic growth andclinical advances By Investing.com
Investing.com· 11 hours agoNRx Pharmaceuticals (NRXP) reported a reduction in net loss and advancements in their clinical...
Earnings call: GeoVax reports progress on key vaccine trials By Investing.com
Investing.com· 10 hours agoCEO David Dodd discussed significant advancements in the company's Phase 2 clinical trials,...
Q1 2024 TRACON Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 15 hours agoWe expect to continue to leverage our platform in two ways that...a lower fixed cost compared to a CRO, but still at a premium to our costs using a pay-for-performance model ...
Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and...
Digital Journal· 13 hours ago...-1010 in Frontiers in Immunology demonstrating the safety and tolerability of the F H AB-derived Interleukin 12 in healthy volunteers Announced early safety data from the company's Phase 1b/2a clinical trial of SON-080 in patients with chemotherapy-induced peripheral neuropathy (CIPN) Received...
Earnings call: Anavex Life Sciences eyes Alzheimer's, Rett syndrome trials By Investing.com
Investing.com· 6 days agoAnavex Life Sciences Corp. (NASDAQ:AVXL) held its fiscal 2024 second-quarter earnings call,...
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
Fairfield-Suisun Daily Republic· 1 day agoKyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune ...
